Cambridge Investment Research Advisors Inc. Sells 66 Shares of Universal Health Services, Inc. (NYSE:UHS)

Cambridge Investment Research Advisors Inc. lowered its stake in shares of Universal Health Services, Inc. (NYSE:UHS) by 3.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,731 shares of the health services provider’s stock after selling 66 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Universal Health Services were worth $325,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in UHS. Norges Bank bought a new stake in Universal Health Services during the 4th quarter worth about $67,964,000. Invesco Ltd. grew its holdings in Universal Health Services by 25.6% during the 4th quarter. Invesco Ltd. now owns 1,241,340 shares of the health services provider’s stock worth $222,721,000 after acquiring an additional 253,385 shares during the last quarter. Freestone Grove Partners LP bought a new stake in Universal Health Services during the 4th quarter worth about $41,155,000. AQR Capital Management LLC grew its holdings in Universal Health Services by 59.4% during the 4th quarter. AQR Capital Management LLC now owns 590,389 shares of the health services provider’s stock worth $105,928,000 after acquiring an additional 219,942 shares during the last quarter. Finally, Bridgewater Associates LP grew its holdings in Universal Health Services by 119.1% during the 4th quarter. Bridgewater Associates LP now owns 322,163 shares of the health services provider’s stock worth $57,802,000 after acquiring an additional 175,131 shares during the last quarter. Institutional investors own 86.05% of the company’s stock.

Universal Health Services Stock Performance

Shares of NYSE:UHS opened at $182.58 on Friday. The company has a market capitalization of $11.87 billion, a price-to-earnings ratio of 10.25, a P/E/G ratio of 0.75 and a beta of 1.28. The firm’s 50 day simple moving average is $183.88 and its 200 day simple moving average is $181.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.32 and a quick ratio of 1.23. Universal Health Services, Inc. has a fifty-two week low of $153.99 and a fifty-two week high of $243.25.

Universal Health Services (NYSE:UHS) last announced its quarterly earnings results on Monday, April 28th. The health services provider reported $4.84 earnings per share for the quarter, beating analysts’ consensus estimates of $4.36 by $0.48. The business had revenue of $4.10 billion for the quarter, compared to the consensus estimate of $4.16 billion. Universal Health Services had a net margin of 7.44% and a return on equity of 17.79%. Universal Health Services’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the company posted $3.70 EPS. As a group, sell-side analysts forecast that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.

Universal Health Services Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Monday, June 2nd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Monday, June 2nd. This represents a $0.80 annualized dividend and a yield of 0.44%. Universal Health Services’s dividend payout ratio (DPR) is currently 4.49%.

Insider Buying and Selling

In other news, Director Maria Ruderman Singer sold 1,097 shares of Universal Health Services stock in a transaction that occurred on Wednesday, May 14th. The shares were sold at an average price of $191.48, for a total value of $210,053.56. Following the sale, the director directly owned 7,884 shares in the company, valued at $1,509,628.32. This trade represents a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 16.40% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on UHS. Barclays increased their price objective on shares of Universal Health Services from $249.00 to $257.00 and gave the stock an “overweight” rating in a report on Tuesday, April 29th. Stephens raised shares of Universal Health Services to a “hold” rating in a research note on Monday, June 2nd. Robert W. Baird reaffirmed a “neutral” rating and issued a $224.00 target price (down previously from $274.00) on shares of Universal Health Services in a research note on Tuesday, April 15th. Royal Bank Of Canada reduced their target price on shares of Universal Health Services from $211.00 to $201.00 and set a “sector perform” rating on the stock in a research note on Wednesday, April 30th. Finally, Baird R W lowered shares of Universal Health Services from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $224.77.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.